Heart valves: St. Jude Medical reports 1st transapical TAVI patient
November 26, 2012 by MassDevice staff
Medical device company St. Jude Medical reports the 1st implantation of its Portico heart valve via transapical delivery through the heart's left ventrical.
St. Jude Medical (NYSE:STJ) reported a milestone for its Portico heart valve today, saying the 1st patient was given the transcatheter aortic valve implant via a catheter threaded through an incision in the apex of the heart's left ventricle.
TAVI devices, used to treat aortic stenosis, are typically delivered via the femoral artery in the leg.
"The first patient implanted with the transapical delivery approach represents a significant milestone in our ongoing efforts to provide physicians a wide range of options to best treat their patients, "Frank Callaghan, president of St. Jude's cardiovascular & ablation technologies arm, said in prepared remarks.
Sign up to get our free newsletters delivered straight to your inbox
Similar entries
- Show full page
- Login to post comments
-
Permalink
RECENT BLOG POSTS
- A cure for coffee breath?
- A Goldilocks approach to leaky blood vessels: Not too stiff, but not too loose
- Optimizing electronic medication administration records
- A bold new vision for Meditech
- Medtech storytelling in the era of comparative effectiveness
- Medical device sales: Wright Medical's pilot program on rep-less sales process worth watching
- Raising an early warning in the ICU: T3
- Staff shakeup underway at Russian medical device regulator
- Heart Rhythm Society 2013 Scientific Session wrap-up
- Physician blogger insights on social media
Navigation
NEWS
Thoratec announces FDA approval of HeartMate II pocket controller
The FDA approves Thoratec's pocket controller for its HeartMate II implantable heart pump.
Devon Medical gains extriCARE CE Mark
Devon Medical wins CE Mark approval in the European Union for its portable extriCARE negative...
Prosthetics makers sue Medicare over payment rules
The American Orthotic and Prosthetic Assn. sues Medicare and the U.S. Health & Human Services...
Pluristem launches Phase I clinical trial to treat tendonitis with stem cells
Pluristem is seeking clinical proof that stem cell therapy can benefit patients with chronic...
GE Healthcare unveils soft tissue imaging technology
GE Healthcare introduces Mavric SL, a novel magnetic resonance imaging technique for joint...
